Phase 2b QUALITY Trial: Enobosarm Significantly Reduces Lean Mass Loss in Patients on Semaglutide Dr. Kamal Kant Kohli31 Jan 2025 9:30 AM ISTEnobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with...
FDA approves Semaglutide for renal protection among diabetes patients with CKD Dr. Kamal Kant Kohli30 Jan 2025 9:00 AM ISTNovo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk of worsening kidney...
Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease Ruchika Sharma29 Jan 2025 1:30 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...
Sun Pharma Labs Gets CDSCO Panel Nod Phase-III clinical trial of Semaglutide solution for injection Dr. Divya Colin27 Jan 2025 6:00 PM ISTNew Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
GLP-1 drugs may reduce surgery complications in patients with diabetes, suggests study Dr. Kamal Kant Kohli15 Jan 2025 8:45 AM ISTPeople with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital...
GLP-1 Drugs May Lower Surgical Complications in Diabetes Patients: Study Finds Dr. Bhumika Maikhuri9 Jan 2025 8:15 AM ISTPeople with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital...
Semaglutide Use in Diabetes Doubles Risk of Irreversible Vision Loss, claims study Dr Riya Dave3 Jan 2025 11:15 AM ISTResearchers have established that the application of once-weekly semaglutide in patients with type 2 diabetes (T2D) increases the risk of nonarteritic...
Semaglutide with Metformin Improves Liver Health and Pancreatic Function in T2DM and NAFLD: Study Reveals Medha Baranwal26 Dec 2024 9:00 AM ISTChina: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, and pancreatic beta-cell...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Tirzepatide versus Semaglutide- Surmount-5 trial reveals head-on comparison results Dr. Prem Aggarwal5 Dec 2024 12:00 PM ISTUS: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company announced that participants...
GLP-1 receptor agonists also protect kidneys among patients with diabetes and obesity: Lancet Dr. Kamal Kant Kohli2 Dec 2024 8:15 AM ISTThe biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have...
Semaglutide associated with Nonarteritic Anterior Ischemic Optic Neuropathy: JAMA Dr Ishan Kataria28 Nov 2024 8:00 PM ISTNonarteritic anterior ischemic optic neuropathy (NAION) is the second most common form of optic neuropathy and a significant cause of blindness...
